Citadel Advisors - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$1,005,245
+358.9%
343,087
+348.0%
0.00%
Q2 2023$219,044
+269.3%
76,589
+172.5%
0.00%
Q4 2022$59,312
-90.6%
28,110
-85.4%
0.00%
Q3 2022$628,000
-8.7%
192,478
-10.3%
0.00%
Q2 2022$688,000
-4.6%
214,583
+110.0%
0.00%
Q1 2022$721,000
+19.8%
102,168
+23.1%
0.00%
Q4 2021$602,000
-47.8%
82,993
-16.5%
0.00%
Q3 2021$1,154,00099,4000.00%
Other shareholders
HUMACYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders